CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-11
DOI
10.1038/s41388-019-1141-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives
- (2019) Tabata T. França et al. Expert Review of Clinical Immunology
- Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
- (2018) David Linehan et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
- (2018) Marco B. Schaaf et al. Cell Death & Disease
- CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells Through SRC and PKC Activation
- (2018) Min Yao et al. MOLECULAR CANCER RESEARCH
- Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
- (2018) Maria Georganaki et al. Frontiers in Immunology
- The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
- (2017) Andrew M K Law et al. ENDOCRINE-RELATED CANCER
- Immunotherapy in Lung Cancer
- (2017) Lingling Du et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Immunotherapy in adult acute leukemia
- (2017) Sabine Blum et al. LEUKEMIA RESEARCH
- Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms
- (2017) Gage Brummer et al. MOLECULAR CANCER RESEARCH
- Continuous Delivery of Neutralizing Antibodies Elevate CCL2 Levels in Mice Bearing MCF10CA1d Breast Tumor Xenografts
- (2017) Min Yao et al. Translational Oncology
- Predictive and prognostic significance of CD8+ tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy
- (2017) Khalid Al-Saleh et al. Oncology Letters
- Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy
- (2016) Samuel Slone et al. CELLULAR SIGNALLING
- Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment
- (2016) E Lefebvre et al. CTS-Clinical and Translational Science
- Tumor angiogenesis—characteristics of tumor endothelial cells
- (2016) Kyoko Hida et al. International Journal of Clinical Oncology
- Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers
- (2016) Min Yao et al. MODERN PATHOLOGY
- The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells
- (2015) Wei Bin Fang et al. BREAST CANCER RESEARCH AND TREATMENT
- Role of CD154 in cancer pathogenesis and immunotherapy
- (2015) Ghada S. Hassan et al. CANCER TREATMENT REVIEWS
- Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients
- (2015) Gary A. Clawson et al. PLoS One
- Loss of Transforming Growth Factor-β Signaling in Mammary Fibroblasts Enhances CCL2 Secretion to Promote Mammary Tumor Progression through Macrophage-Dependent and -Independent Mechanisms
- (2015) Stacey L. Hembruff et al. NEOPLASIA
- Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer
- (2014) Carol S. Connor et al. JOURNAL OF SURGICAL ONCOLOGY
- Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient Endothelium
- (2014) Victoria Youngblood et al. MOLECULAR CANCER RESEARCH
- Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
- (2013) A N Seo et al. BRITISH JOURNAL OF CANCER
- Inflammatory chemokines and metastasis—tracing the accessory
- (2013) L Borsig et al. ONCOGENE
- Phospholipase Cɛ links G protein-coupled receptor activation to inflammatory astrocytic responses
- (2013) Stephanie S. Dusaban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a Highly Selective c-Src Kinase Inhibitor
- (2012) Kristoffer R. Brandvold et al. ACS Chemical Biology
- T-cell-independent Antitumor Effects of CD40 Ligation
- (2012) Alexander L. Rakhmilevich et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms
- (2012) Wei Bin Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-6 deficiency exacerbates skin inflammation in a murine model of irritant dermatitis
- (2012) Eric G. Lee et al. Journal of Immunotoxicology
- Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s)
- (2012) K C Scribner et al. ONCOGENE
- Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression
- (2011) Wei Bin Fang et al. CLINICAL & EXPERIMENTAL METASTASIS
- Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model
- (2011) Kelli Elizabeth Valdez et al. JOURNAL OF PATHOLOGY
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- Calcium Condensed LABL-TAT Complexes Effectively Target Gene Delivery to ICAM-1 Expressing Cells
- (2011) Supang Khondee et al. MOLECULAR PHARMACEUTICS
- Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
- (2011) Chu-Biao Xue et al. ACS Medicinal Chemistry Letters
- Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells
- (2010) Lara Pickel et al. CANCER BIOLOGY & THERAPY
- Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA2 Repression of Slit2 Tumor Suppressor Function in Endothelium
- (2010) D. M. Brantley-Sieders et al. CANCER RESEARCH
- Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells
- (2010) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Negative Feedback Control of Osteoclast Formation through Ubiquitin-mediated Down-regulation of NFATc1
- (2009) Jung Ha Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- “Soft” Calcium Crosslinks Enable Highly Efficient Gene Transfection Using TAT Peptide
- (2009) Abdulgader Baoum et al. PHARMACEUTICAL RESEARCH
- β-Arrestin1 interacts with the G-protein subunits β1γ2 and promotes β1γ2-dependent Akt signalling for NF-κB activation
- (2008) Ming Yang et al. BIOCHEMICAL JOURNAL
- Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes
- (2008) S. A. Crist et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation